Septorhinoplasty is a crucial intervention in functional and aesthetic facial surgery. Although rare and usually manageable, complications could lead to disfiguring consequences. There is no universal protocol for perioperative management in the literature. The aim of this article is to analyze the surgical complications in patients who underwent open rhinoseptoplasty and were treated in the perioperative period with the standardized protocol used in our department, in order to propose it as a standardized protocol for a more global application. Methods: The patients included underwent rhinoplasty between 2017 and 2022 and were managed with the same treatment protocol. Perioperative and intraoperative data, as well as possible complications, were collected. Results: A total of 129 patients were included, 73% of which reported either mild or no complications. Abnormal scar healing was the most frequent complaint (9%), followed by edema (6.2%), nasal dyspnea (3.9%), infection (2.3%), and bleeding (2.3%). No severe complications were reported. Conclusions: Our protocol appears to be effective in minimizing complications such as infection and bleeding, although it is very difficult to compare the results with the literature.

Venous malformations (VMs) are some of the most common vascular malformations. Their treatment varies from laser to sclerotherapy and surgery. For many years, radiofrequency and argon plasma devices have been used on soft tissues VMs. However, their use has been limited because of high thermal impact of nearby structures. The here described cold-helium plasma electrosurgical device carries intrinsic bio-technical advantages, as the helium plasma beam manages to move towards tissues with less impedance, such as VM vessels. The primary objective of this study was to assess if J-Plasma® could be effective on treating the superficial portion of VMs, in a single or multimodal approach. From January 2022 to January 2024, 17 patients affected by head and neck VM involving mucosa or skin were treated using J-Plasma®, in addition to sclerotherapy. More than 1 session was needed in all but 1 patient. All patients showed a progressive shrinkage of the venous chambers and thickening of the surface, while no major intraoperative and perioperative complications, such as necrosis or severe bleeding were observed. Minor complications like oedema or exfoliation were mild. All 17 patients had a complete healing of the mucosal surface one week after treatment. The grade of effectiveness and the stability of the results correlated with the complexity of the VMs. This research may serve as groundwork for future studies that may aim to explore the use of this device on other vascular malformations. LEVEL OF EVIDENCE: Case series: level 4.

This case series and literature review introduces Bony Vascular Malformations (BVM) of facial bones as a well-defined entity to provide a more accurate reference to these often mislabeled vascular anomalies, aiming to standardize terminology, elucidate their clinical-radiological features and guide their management. This retrospective review analyzes 20 patients treated between 2017 and 2024, all affected by venous malformations involving facial bones. Facial BVMs are apparently rarer than spine or skull bony venous malformations, but they are often misdiagnosed as hemangiomas and, as such statistics are unreliable. Patients presented with symptoms such as facial asymmetry, pain or malocclusion, depending on lesion location. Diagnosis was done on CT scans and confirmed at MRI, when needed. Histopathology offered diagnostic value. Treatment should be tailored, with surgical en-bloc resection remaining the mainstay, but a partial or a more conservative approach might be preferred for treating BVMs of the jaws, with decision-making driven by lesion location, patients' age, symptoms and risk of complications. Outcomes were favorable, with no periprocedural complications and durable symptom control. By defining BVM as a unified diagnostic category, the Authors aim to support a more consistent classification. Inference from this large case series provides clou for diagnosis and suggests tailored management. LEVEL OF EVIDENCE: Case series: level 4.

The aim of the present study is to conduct a descriptive epidemiological analysis of clinical and histopathological data related to the treatment of squamous cell carcinoma of the oral cavity in a population of elderly patients. To address the research inquiries, a population of patients diagnosed with oral cancer at the Maxillofacial Unit of Verona University between 1997 and 2017 was considered. To create the descriptive statistics of the sample population, the following parameters were collected: sex, age, site of the tumor, frequency and type of surgical reconstruction, frequency of pathological staging (pTNM), postoperative hospitalization duration, disease recurrence, overall survival, disease-specific survival, and disease-free survival. Three hundred eighty-six patients met the inclusion criteria; the population was divided into two groups: patients aged <75 years and patients aged ≥75 years. The male-to-female ratio in the overall population was 1.41:1. In the entire sample, the primary site of localization of disease was found to be the tongue. A total of 37.3% of patients underwent microvascular flap reconstruction. Reconstruction with a pedicled flap was used in 27.7% of patients under 75 years old and in 11% of patients over 75 years old. Minor reconstructions using local flaps were performed in 14% of cases. Globally, the average length of postoperative hospital stay (LOS) was 15.8 days for patients aged <75 years and 14.5 days for patients aged ≥75 years. Cancer recurrence was registered in 50% of patients under 75 years and 45% of patients over 75 years. Overall survival in patients aged <75 years was 74%, 65,7%, 50.3% at 3, 5, and 10 years, respectively. Overall survival in patients aged ≥75 years was 63.6%, 50.1%, and 23.2% at 3, 5, and 10 years, respectively. The findings of the present study show that squamous cell carcinoma of the oral cavity in patients aged 75 years or older is a relatively frequent pathology that has been increasing in recent decades, likely due to the progressive aging of the general population. The disease is more prevalent in women, who have greater longevity, and in this subgroup, cancer primarily affects the gingiva. Age alone was not found to be a determining factor, whereas the difference observed in overall survival highlights the importance of comorbidities in elderly patients, which must be carefully evaluated and managed before initiating any therapeutic pathway. Finally, the results of this study emphasize the importance of early diagnosis to ensure that patients receive the most appropriate treatment while minimizing invasiveness.